Entry Point Capital, LLC Penumbra Inc Call Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PEN
# of Institutions
376Shares Held
30.1MCall Options Held
285KPut Options Held
168K-
Black Rock Inc. New York, NY4.26MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.7MShares$874 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.03MShares$715 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.28MShares$304 Million1.46% of portfolio
-
State Street Corp Boston, MA1.23MShares$291 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $8.96B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...